The immunosuppressive tumor microenvironment in ovarian cancer is a major obstacle to effective immunotherapy, as high levels of immunosuppressive molecules like VEGF and IL-10 induce regulatory T Cell differentiation and further inhibit the immune response of effector T lymphocytes against the tumor (Metz et al., 1975). Here, VEGFA is linked to ovarian carcinoma.